STEPHEN T WILLS
CIK 1103883 · Executive VP and CFO/COO · last filed 2026-07-17
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$491.3K
Companies
3
Total Filings
93
Lifetime Open-Market Net
$225.09M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PTN | Executive VP and CFO/COO | 63,965 | $7.68 | $491.3K | $225.10M | 62 | 2026-07-17 |
| Gamida Cell Ltd. (GMDA) Delisted | Director | 256,177 | $0.03 | $8.4K | $15.0K | 5 | 2024-02-02 |
| DERMA SCIENCES, INC. (DSCI) Delisted | Director | 27,500 | — | — | -$31.4K | 18 | 2017-02-24 |
Recent Filings · Page 5 of 10
93 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-02-03 | PTN | Grant (A) | +300,000 | $0 | EDGAR |
| 2017-02-03 | PTN | Grant (A) | +300,000 | $0 | EDGAR |
| 2016-09-08 | PTN | Grant (A) | +268,000 | $0 | EDGAR |
| 2016-06-28 | PTN | Mixed | +52,185 | -$10.3K | EDGAR |
| 2016-06-13 | PTN | Mixed | +66,101 | -$14.2K | EDGAR |
| 2016-06-03 | DERMA SCIENCES, INC. (DSCI) Delisted | Grant (A) | +27,500 | $0 | EDGAR |
| 2015-12-23 | DERMA SCIENCES, INC. (DSCI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-12-10 | PTN | Grant (A) | +300,000 | $0 | EDGAR |
| 2015-08-14 | DERMA SCIENCES, INC. (DSCI) Delisted | Buy (P) | +10,000 | $64.5K | EDGAR |
| 2015-06-30 | PTN | Mixed | +69,580 | -$27.7K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.